RCUS
RCUS
NYSE · Biotechnology

Arcus Biosciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$21.64
-0.79 (-3.52%)
As of Mar 22, 10:01 PM ET ·
Analyst Consensus
Strong Buy
18
Analysts
High
Coverage
Buy 14 78%
Hold 4 22%
Sell 0 0%
Price Target
Analyst Price Target +364.4% upside
Low Target $77.00
Average Target $100.50
High Target $121.27
Current Price $21.64
Current
$21.64
Target
$100.50
$77.00 $100.50 avg $121.27
Scenario Analysis
Bear Case
$77.00
255.8%
Low target
Base Case
$100.50
+364.4%
Avg target
Bull Case
$121.27
+460.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$26.40
-18.0% from high
52-Week Low
$6.50
+232.9% from low
50-Day SMA
$22.13
-2.2% vs SMA
200-Day SMA
$15.14
+42.9% vs SMA
RSI (14)
36.6
Neutral
Target vs 52W High
$100.50
+280.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -26.5%